Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Gábor Tajti

Medical University of Vienna

Austria

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

LinkedIn ORCID

Google Scholar

Research Interests

Immunology

60%

Cell Biology

20%

Inflammatory Biology

20%

T Cell Biology

20%

Neuropeptide

20%

Biologic Therapy

20%

Vaccinology

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles17

Cyclophilin–CD147 interaction enables SARS-CoV-2 infection of human monocytes and their activation via Toll-like receptors 7 and 8

Article Link

Year:

2025

SARS-CoV-2 hijacks host CD55, CD59 and factor H to impair antibody-dependent complement-mediated lysis

Article Link

Year:

2024

Vaccine Based on Recombinant Fusion Protein Combining Hepatitis B Virus PreS with SARS-CoV-2 Wild-Type- and Omicron-Derived Receptor Binding Domain Strongly Induces Omicron-Neutralizing Antibodies in a Murine Model

Article Link

Year:

2024

Time to Kill and Time to Heal: The Multifaceted Role of Lactoferrin and Lactoferricin in Host Defense

Article Link

Year:

2023

Effects of 1-year tofacitinib therapy on angiogenic biomarkers in rheumatoid arthritis

Article Link

Year:

2023

Effects of One-Year Tofacitinib Therapy on Lipids and Adipokines in Association with Vascular Pathophysiology in Rheumatoid Arthritis

Article Link

Year:

2022

Full seroconversion in initial non-responders with higher antibody levels after heterologous COVID-19 vaccination schedule.

Article Link

Year:

2022

SARS-CoV-2-mRNA Booster Vaccination Reverses Non-Responsiveness and Early Antibody Waning in Immunocompromised Patients – A Phase Four Study Comparing Immune Responses in Patients With Solid Cancers, Multiple Myeloma and Inflammatory Bowel Disease

Article Link

Year:

2022

Blockade of TMPRSS2-mediated priming of SARS-CoV-2 by lactoferricin

Article Link

Year:

2022

Mapping the functional expression of auxiliary subunits of KCa1.1 in glioblastoma

Article Link

Year:

2022

Immunomagnetic separation is a suitable method for electrophysiology and ion channel pharmacology studies on T cells.

Article Link

Year:

2021

Optimization of Pichia pastoris Expression System for High-Level Production of Margatoxin.

Article Link

Year:

2021

Effects of one-year tofacitinib therapy on bone metabolism in rheumatoid arthritis.

Article Link

Year:

2021

The Kv1.3 K+ channel in the immune system and its "precision pharmacology" using peptide toxins.

Article Link

Year:

2021

The voltage-gated potassium channel KV1.3 as a therapeutic target for venom-derived peptides.

Article Link

Year:

2020

The voltage-gated proton channel hHv1 is functionally expressed in human chorion-derived mesenchymal stem cells.

Article Link

Year:

2020

Periodic Membrane Potential and Ca2+ Oscillations in T Cells Forming an Immune Synapse.

Article Link

Year:

2020

Collaborators9

Hannes Stockinger

University Professor

Medical University of Vienna

AUSTRIA

Gyorgy Panyi

professor

University of Debrecen

HUNGARY

Al Nasar Ahmed Sehgal

Medical University of Vienna

AUSTRIA

Zoltán Szekanecz

University of Debrecen

HUNGARY

Winfried F. Pickl

AUSTRIA

Ursula Wiedermann

Medical University of Vienna

AUSTRIA

Endre Kokai

senior lecturer

University of Debrecen

HUNGARY

Vladimir Leksa

Medical University of Vienna

AUSTRIA

Gabriella Szucs

MD, professor

University of Debrecen Medical School and Health Science Center

HUNGARY

How do I reach out?

Meet Kite AI

Gábor Tajti

How do I reach out?

Contact this professor

Research Interests

Ask ApplyKite AI

Articles17

Cyclophilin–CD147 interaction enables SARS-CoV-2 infection of human monocytes and their activation via Toll-like receptors 7 and 8

SARS-CoV-2 hijacks host CD55, CD59 and factor H to impair antibody-dependent complement-mediated lysis

Vaccine Based on Recombinant Fusion Protein Combining Hepatitis B Virus PreS with SARS-CoV-2 Wild-Type- and Omicron-Derived Receptor Binding Domain Strongly Induces Omicron-Neutralizing Antibodies in a Murine Model

Time to Kill and Time to Heal: The Multifaceted Role of Lactoferrin and Lactoferricin in Host Defense

Effects of 1-year tofacitinib therapy on angiogenic biomarkers in rheumatoid arthritis

Effects of One-Year Tofacitinib Therapy on Lipids and Adipokines in Association with Vascular Pathophysiology in Rheumatoid Arthritis

Full seroconversion in initial non-responders with higher antibody levels after heterologous COVID-19 vaccination schedule.

SARS-CoV-2-mRNA Booster Vaccination Reverses Non-Responsiveness and Early Antibody Waning in Immunocompromised Patients – A Phase Four Study Comparing Immune Responses in Patients With Solid Cancers, Multiple Myeloma and Inflammatory Bowel Disease

Blockade of TMPRSS2-mediated priming of SARS-CoV-2 by lactoferricin

Mapping the functional expression of auxiliary subunits of K<sub>Ca</sub>1.1 in glioblastoma

Immunomagnetic separation is a suitable method for electrophysiology and ion channel pharmacology studies on T cells.

Optimization of <i>Pichia pastoris</i> Expression System for High-Level Production of Margatoxin.

Effects of one-year tofacitinib therapy on bone metabolism in rheumatoid arthritis.

The Kv1.3 K<sup>+</sup> channel in the immune system and its "precision pharmacology" using peptide toxins.

The voltage-gated potassium channel K<sub>V</sub>1.3 as a therapeutic target for venom-derived peptides.

The voltage-gated proton channel hHv1 is functionally expressed in human chorion-derived mesenchymal stem cells.

Periodic Membrane Potential and Ca2+ Oscillations in T Cells Forming an Immune Synapse.

Collaborators9

Hannes Stockinger

Gyorgy Panyi

Al Nasar Ahmed Sehgal

Zoltán Szekanecz

Winfried F. Pickl

Ursula Wiedermann

Endre Kokai

Vladimir Leksa

Gabriella Szucs

How do I reach out?